You are here GEAR Mind Maps References

References


  • Barbieri, M., Drummond, M., Rutten, F., Cook, J., Glick, H. A., et al. (2010) 'What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?', Value in Health, 13(8), 1028-1037.
  • Bill and Melinda Gates Foundation (2014) Methods for Economic Evaluation Project (MEEP) The Gates Reference Case.
  • Brazier, J., Ratcliffe, J., Salomon, J. A. and Tsuchiya, A. (2007) Measuring and Valuing Health Benefits for Economic Evaluation, OUP Oxford.
  • Brazier, J., Roberts, J. and Deverill, M. (2002) 'The estimation of a preference-based measure of health from the SF-36', J Health Econ, 21(2), 271-92.
  • Brazier, J. E., Yang, Y., Tsuchiya, A. and Rowen, D. L. (2010) 'A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures', Eur J Health Econ, 11(2), 215-25.
  • Brooks, R. (1996) 'EuroQol: the current state of play', Health Policy, 37(1), 53-72.
  • Dakin, H. (2013) 'Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database', Health and Quality of Life Outcomes, 11(1), 1-6.
  • Drummond, M., Barbieri, M., Cook, J., Glick, H. A., Lis, J., et al. (2009) 'Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report', Value Health, 12(4), 409-18.
  • Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L. and Torrance, G. W. (2015) Methods for the Economic Evaluation of Health Care Programmes, Fourth Edition ed., Oxford university press.
  • EuroQol Group (1990) 'EuroQol--a new facility for the measurement of health-related quality of life', Health Policy, 16(3), 199-208.
  • Fayers, P. and Bottomley, A. (2002) 'Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer', Eur J Cancer, 38 Suppl 4, S125-33.
  • Goeree, R., Burke, N., O'Reilly, D., Manca, A., Blackhouse, G., et al. (2007) 'Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another', Curr Med Res Opin, 23(4), 671-82.
  • Gold, M. R., Siegel, J. E., Russell, L. B. and Weinstein, M. C. (1996) Cost-effectiveness in health and medicine, Oxford University Press.
  • Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., et al. (2011) 'Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)', Quality of Life Research, 20(10), 1727-1736.
  • Horsman, J., Furlong, W., Feeny, D. and Torrance, G. (2003) 'The Health Utilities Index (HUI®): concepts, measurement properties and applications', Health and Quality of Life Outcomes, 1(1), 1-13.
  • Jones, P. W., Quirk, F. H., Baveystock, C. M. and Littlejohns, P. (1992) 'A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire', Am Rev Respir Dis, 145(6), 1321-7.
  • Murray, C. J., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., et al. (2012) 'Supplementary appendix to: Comprehensive systematic analysis of global epidemiology: Definitions, methods, simplification of DALYs, and comparative results from the Global Burden of Disease Study 2010', Lancet, 380.
  • Murray, C. J. L. and Lopez, A. D. (1996) The Global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 Cambridge, MA: Harvard University Press.
  • Reenen, M. v., Janssen , B., Oppe, M., Kreimeier, S. and Greiner, W. (2014) "EQ-5D-Y user guide." Basic information on how to use the EQ-5D-Y instrument., 1.0, Rotterdam: EuroQol Group 
  • Salomon, J. A., Haagsma, J. A., Davis, A., de Noordhout, C. M., Polinder, S., et al. (2015) 'Disability weights for the Global Burden of Disease 2013 study', The Lancet Global Health, 3(11), e712-e723.
  • Sanders, G. D., Neumann, P. J., Basu, A. and et al. (2016) 'Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine', JAMA, 316(10), 1093-1103.
  • Tan-Torres Edejer, T., Baltussen, R., Adam, T., Hutubessy, R., Acharya, A., et al. (2003) Making Choices in Health : WHO guide to cost-effectiveness analysis, Geneva: World Health Organization.
  • Wille, N., Badia, X., Bonsel, G., Burström, K., Cavrini, G., et al. (2010) 'Development of the EQ-5D-Y: a child-friendly version of the EQ-5D', Quality of Life Research, 19(6), 875-886.